FISABIO
Valencia, Spain
Research institute in Valencia
Av. de Catalunya, 21, 46020 València, Valencia
About FISABIO
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at FISABIO
During the past decade, FISABIO conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Radiation Therapy in Treating Patients With Stage I, Stage II, or Stage III Prostate Cancer
1997-12-01
2015-01-01
Completed
450
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer
1999-01-04
2007-03-31
Completed
350
High-Dose Fluorouracil With or Without Leucovorin Compared With Standard Fluorouracil Plus Leucovorin Following Surgery in Treating Patients With Stage III Colon Cancer
1999-03-01
2007-04-01
Completed
Radiation Therapy in Patients With Limited-Stage Small Cell Lung Cancer in Complete Remission
1999-09-01
2005-12-01
Completed
Second-look Surgery With or Without Intraperitoneal Chemotherapy in Treating Patients With Recurrent Colorectal Cancer
1999-07-01
2003-10-01
Terminated
Combination Chemotherapy With or Without Irinotecan in Treating Patients With Stage III Colon Cancer
1998-07-22
2007-09-01
Completed
Chemotherapy in Treating Patients With Locally Advanced or Metastatic Cancer of the Pancreas or Bile Duct
1999-01-01
Unknown status
Surgery With or Without Radiation Therapy and Chemotherapy in Treating Patients With Esophageal Cancer
2002-05-01
2010-09-01
Completed
195
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at FISABIO
According to Clinical.Site data, the most researched conditions in "FISABIO" are
"Meningococcal Vaccine" (1 trials) and "Pneumococcal Disease" (1 trials). Many other conditions were trialed in "FISABIO" in a lesser frequency.
Clinical Trials Intervention Types at FISABIO
Most popular intervention types in "FISABIO" are "Biological" (2 trials), "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "13-valent pneumococcal conjugate vaccine" (1 trials), "20-valent pneumococcal conjugate vaccine" (1 trials), "Bexsero" (1 trials), "Bivalent rLP2086 (120-µg Dose)" (1 trials) and "Bivalent rLP2086 (60-µg Dose)" (1 trials). Other intervention names were less common.
Clinical Trials Genders at FISABIO
The vast majority of trials in "FISABIO" are
2 trials for "All" genders.
Clinical Trials Status at FISABIO
Currently, there are NaN active trials in "FISABIO".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in FISABIO,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in FISABIO, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".